National Academies Press: OpenBook
« Previous: Glossary
Suggested Citation:"Acronyms." Institute of Medicine. 2004. New Frontiers in Contraceptive Research: A Blueprint for Action. Washington, DC: The National Academies Press. doi: 10.17226/10905.
×
Page 231
Suggested Citation:"Acronyms." Institute of Medicine. 2004. New Frontiers in Contraceptive Research: A Blueprint for Action. Washington, DC: The National Academies Press. doi: 10.17226/10905.
×
Page 232

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Acronyms AIDS Acquired Immune Deficiency Syndrome AMPPA Application of Molecular Pharmacology for Post-Testicular Activity BLA Biologics License Application CDC Center for Disease Control and Prevention cDNA complementary DNA CICCR—Consortium for Industrial Collaboration in Contraceptive Research CIR-LRP Contraception and Infertility Loan Repayment Program EM Electron Microscopy EST Expressed Sequence Tag FDA Food and Drug Administration PHI Family Health International FIC/NIEHS Fogerty International Center/ National Institute of Environment Health Services FSH follicle stimulating hormone GATB Global Alliance for TB Drug Development GLP Good Laboratory Practice GMP Global Microbicide Project GMP Good Manufacturing Practice GnRH gonadotropin releasing hormone 231

232 GPI Glycosyl Phosphatidylinositol hCG human chorionic gonadotropin HIV Human Immuno-deficiency Virus HPTN HIV Prevention Trials Network HTS High Throughput Screening NEW FRONTIERS IN CONTRACEPTIVE RESEARCH ICCR International Committee for Contraception Research IND Investigational New Drug IOM Institute of Medicine IUD Intrauterine Device LCST Lower Critical Solution Temperature LNG-IUS Levonorgestrel-releasing intra-uterine system LH luteinizing hormone NCI National Cancer Institute NDA New Drug Application NICHD National Institute of Child Health and Human Development NIH National Institutes of Health NMR Nuclear Magnetic Resonance OR Olfactory Receptor ORE Open Reading Frame PQS Protein Quaternary Structure RAID Rapid acess to intervention development R.A.N.D rapid access to NCI discovery resources RNAi RNA interference SST Signal Sequence Trap STI Sexually Transmitted Infection UNFPA United Nations Population Fund USAID United States Agency for International Development USDA United States Department of Agriculture WHO World Health Organization

New Frontiers in Contraceptive Research: A Blueprint for Action Get This Book
×
 New Frontiers in Contraceptive Research: A Blueprint for Action
Buy Paperback | $55.00 Buy Ebook | $43.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

More than a quarter of pregnancies worldwide are unintended. Between 1995 and 2000, nearly 700,000 women died and many more experienced illness, injury, and disability as a result of unintended pregnancy. Children born from unplanned conception are at greater risk of low birth weight, of being abused, and of not receiving sufficient resources for healthy development. A wider range of contraceptive options is needed to address the changing needs of the populations of the world across the reproductive life cycle, but this unmet need has not been a major priority of the research community and pharmaceutical industry. New Frontiers in Contraceptive Research: A Blueprint for Action, a new report from the Institute of Medicine of the National Academies, identifies priority areas for research to develop new contraceptives. The report highlights new technologies and approaches to biomedical research, including genomics and proteomics, which hold particular promise for developing new products. It also identifies impediments to drug development that must be addressed. Research sponsors, both public and private, will find topics of interest among the recommendations, which are diverse but interconnected and important for improving the range of contraceptive products, their efficacy, and their acceptability.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!